This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Georges Joseph Cornelius Hoomaert: Innovator in HIV Research
Introduction
Georges Joseph Cornelius Hoomaert is a notable inventor based in Kessel-lo, Belgium. He has made significant contributions to the field of medicine, particularly in the development of HIV replication inhibitors. His work has the potential to impact the treatment of HIV, a critical area of research in modern medicine.
Latest Patents
Hoomaert holds 1 patent related to his invention of HIV inhibiting 1,2,4-triazines. This patent describes the use of these compounds as HIV replication inhibitors, detailing their formula and processes for preparation. The pharmaceutical compositions comprising these inhibitors are aimed at providing new avenues for medical treatment.
Career Highlights
Hoomaert is associated with Janssen Pharmaceutica NV, a prominent company in the pharmaceutical industry. His work at this organization has allowed him to focus on innovative solutions for combating HIV, contributing to the broader efforts in public health.
Collaborations
Throughout his career, Hoomaert has collaborated with esteemed colleagues, including Paulus Joannes Lewi and Paul Adriaan Jan Janssen. These partnerships have fostered a collaborative environment that enhances research and development in the pharmaceutical sector.
Conclusion
Georges Joseph Cornelius Hoomaert is a key figure in the fight against HIV, with his innovative patent contributing to the development of effective treatments. His work exemplifies the importance of research and collaboration in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile